<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00844389</url>
  </required_header>
  <id_info>
    <org_study_id>ACT45-GLAUC</org_study_id>
    <nct_id>NCT00844389</nct_id>
  </id_info>
  <brief_title>Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy</brief_title>
  <official_title>Near to Infrared Light Stimulation Effect on Ganglion Cell Function in Glaucomatous Optic Neuropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Valparaiso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Comisión Nacional de Investigación Científica y Tecnológica</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad de Valparaiso</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate if near-to-infrared light stimulation can improve
      retinal ganglion cell function in glaucomatous patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ganglion cell dysfunction in glaucomatous optic neuropathy has been ascribed to ganglion cell
      electrophysiological inactivation and to apoptotic cell death. Near-to-infrared light
      stimulation has been used to induce mitochondrial activation and to prevent apoptotic death
      through mitochondrial cytochrome oxidase c stimulation. Near-to-infrared light stimulation
      might be useful to induce ganglion cell activation and inhibit apoptotic cell death.

      We propose that near-to-infrared light stimulation can be used as an adjuvant treatment
      combined with ocular hypotensive treatment in glaucomatous patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">March 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pattern electroretinogram response</measure>
    <time_frame>Every two weeks for 4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>OCT ganglion cell layer average thickness, Visual Field defects</measure>
    <time_frame>Every month for four months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>NIR light</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of patients stimulated with near to infrared light daily stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Green light</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group of patients stimulated with green light.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Near to infrared light retinal stimulation</intervention_name>
    <description>Patients will be stimulated with 660 nm light frequency through a LED device. Patients will be stimulated daily for two minutes for a 6 month period.</description>
    <arm_group_label>NIR light</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Green light stimulation</intervention_name>
    <description>Patients will be stimulated with 530 nm LED light frequency through a LED device. Patients will be stimulated daily for two minutes for a 6 month period.</description>
    <arm_group_label>Green light</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnose of Ocular Hypertension (cup to disk ratio 0,6 or less, normal
             Humphrey 24-2 visual field with aplanatic IOP over 21 mmHg) or Mild Glaucoma (cup to
             disk ratio 0,6 to 0,8, characteristic Humphrey 24-2 visual field defect PSD between 3
             and 6 dB).

          -  Visual acuity 20/40 or better

        Exclusion Criteria:

          -  Diabetic retinopathy, Multiple Sclerosis, Parkinson disease

          -  Refractive error of 3 diopters or more
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tatiana E Cevo, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad de Valparaiso</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adrian Palacios, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universidad de Valparaiso</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Servicio de Oftalmología Hospital Van Buren</name>
      <address>
        <city>Valparaiso</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2009</study_first_submitted>
  <study_first_submitted_qc>February 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2009</study_first_posted>
  <last_update_submitted>September 30, 2009</last_update_submitted>
  <last_update_submitted_qc>September 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 1, 2009</last_update_posted>
  <responsible_party>
    <name_title>Tatiana Cevo</name_title>
    <organization>Universidad de Valparaíso</organization>
  </responsible_party>
  <keyword>Open Angle Glaucoma</keyword>
  <keyword>Biophotomodulation</keyword>
  <keyword>Near to Infrared light stimulation</keyword>
  <keyword>Neuroprotection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Optic Nerve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

